APOTREM
ActiveDirectors
Directors
2 directors, last change in 2026
Board 2
Giura Pharma
Current
Director · since 15-12-2025 · term without a fixed end · Private limited company · permanent representative: Caroline Caenepeel · listed in the 2025 annual accounts, filed on 09-06-2026
Pharma Deprée
Current
Director · since 15-12-2025 · term without a fixed end · Private limited company · permanent representative: Inne Deprée · listed in the 2025 annual accounts, filed on 09-06-2026
Permanent representatives 2
Caroline Caenepeel
Current
Permanent representative · appointed in the act of 06-01-2026 · for Giura Pharma
Inne Deprée
Current
Permanent representative · appointed in the act of 06-01-2026 · for Pharma Deprée
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 06-01-2026Owners and capital
Shareholders
2 ownersOwners 2
- Equity €461,457 Profit of €81,021 in 2025 (profit of €72,134 in 2024)50%
- Equity €257,179 Profit of €67,217 in 2025 (profit of €61,455 in 2024)50%
Capital transactions
Capital over time
- 11-12-2025 Capital increase of €313,000 · to €331,600 · no new shares · in cash
- 11-12-2025 Capital increase of €313,000 · no new shares
Mandate history
3 people, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Giura Pharma |
|
| Pharma Deprée |
|
| Louis Van Tendeloo |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “1, De algemene vergadering die de bestuurder(s) benoemt bepaalt hun aantal,de duur van hun opdracht en,indien er meerdere bestuurders…”
Articles of association, deed of 14-01-2022 (in Dutch)